- Barr Pharmaceuticals
-
Barr Pharmaceuticals Inc 
Industry Pharmaceuticals & Medical Devices Founded New York (1970) Headquarters Montvale, NJ, USA Key people Bruce Downey, CEO Products Generic and Proprietary Pharmaceuticals Revenue Over $1 Billion USD fiscal year 2005 Employees 2000 Barr Pharmaceuticals, Inc., was a global specialty pharmaceutical company that operated in more than 30 countries worldwide. Barr were engaged in the development, manufacture and marketing of generic and proprietary pharmaceuticals, biopharmaceuticals and active pharmaceutical ingredients.
History
Barr Laboratories, Inc. was founded in 1970 by Edwin A. Cohen and was ultimately taken public under his leadership.
On July 18, 2008 it was announced that rival firm - Teva Pharmaceutical Industries Ltd, would acquire Barr Pharmaceuticals Inc for $7.46 billion plus the assumption of net debt of approximately $1.5 billion.[1] Today Barr Laboratories exists only as a sub-division of Teva Pharmaceuticals, as part of the Teva Active Pharmaceutical Ingredients (TAPI) division.
Teva Pharmaceuticals develops and markets generic pharmaceuticals under various brand names - including the Barr Laboratories, Inc. label. Teva Pharmaceuticals is the largest generic drug manufacturer in the world.
References
- ^ Staff (2008-07-21), "Teva Coughs Up $7.46B for Barr Reinforcing Its Number One Spot in the Generics Market", Genetic Engineering & Biotechnology News, GEN News Highlights (Mary Ann Liebert), ISSN 1937-8661, http://www.genengnews.com/news/bnitem.aspx?name=38938670, retrieved 2008-09-26
Categories:- Pharmaceutical companies of the United States
Wikimedia Foundation. 2010.
